Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.49 +0.00 (+0.80%)
As of: Sep 30, 2026 · 12:03 PM EDT

Pasithea Therapeutics Corp. (KTTA) Operating Leases (2022 - 2023)

Updated

Pasithea Therapeutics (KTTA) posted Operating Leases of $210,817 for Q3 2023, down 70.9% from $724,386 a year earlier and down 17.7% from the prior quarter.

Analysis

Pasithea Therapeutics Corp. (KTTA) Operating Leases (2022 - 2023) Analysis & Trends

At the end of FY2022, Pasithea Therapeutics' Operating Leases came in at $344,021.

  • According to Business Quant data, Operating Leases for the three prior quarters was $256,084 (Q2 2023), $300,480 (Q1 2023) and $344,021 (Q4 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 210,817.00
Jun 30, 2023 256,084.00
Mar 31, 2023 300,480.00
Dec 31, 2022 344,021.00
Sep 30, 2022 724,386.00
Jun 30, 2022 358,245.00
API Access

Pasithea Therapeutics Corp. Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=KTTA&period=max&api_key=YOUR_API_KEY